Jeryl L. Hilleman, Director at NovoCure Ltd (NVCR), sold 999 shares at $17.26 ($17K) on 2025-06-03, disclosed to the SEC on 2025-06-04.
Seasonal sale ($17k) by Director — this insider has traded NVCR in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| NVCR | SELL | 2022-06-16 | $28K | — | Filing → |
| SIBN | SELL | 2022-06-14 | $27K | — | Filing → |
| SIBN | SELL | 2021-06-28 | $148K | — | Filing → |